FDA Employees’ Outside Activities Will Receive Scrutiny By Center Directors
This article was originally published in The Pink Sheet Daily
Executive Summary
Activities had been approved at lower levels, but the interim policy – issued following questions about behavior of NIH scientists – escalates the oversight. All outside activities by FDA employees will be reviewed as part of the development of a final policy.
You may also be interested in...
FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
Energy & Commerce Committee wants copies of all approved and rejected consulting requests since 1999. FDA is one of 15 agencies to receive the request as the committee looks beyond NIH.
FDA Conflict Of Interest Policies Will Be Reviewed By House Committee
Energy & Commerce Committee wants copies of all approved and rejected consulting requests since 1999. FDA is one of 15 agencies to receive the request as the committee looks beyond NIH.
FDA Will Increase Financial Disclosure Requirements For Employees
Move follows the decision to have center directors vet employees’ consulting arrangements. Agency-wide review of outside activity requests finds no further conflicts beyond a situation at CBER that was questioned by the House Energy & Commerce Committee.